Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-13.72	49.61	57.49
Graham Fair Price	9.10	13.74	12.59
PEG	110.25	1.22	0.58
Price/Book	10.80	3.09	2.79
Price/Cash Flow	301.85	124.30	30.93
Prices/Earnings	-5.66	20.37	21.59
Price/Sales	19.81	5.56	4.64
Price/FCF	301.85	124.30	30.93
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	8.75	0.32	0.29
Operating Margin	15.22	0.11	0.09
ROA	17.58	0.01	0.01
ROE	0.03	0.04	17.45
ROIC	0.03	0.03	-5.64
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.06	89.23
Dividends QOQ	< 0.005	0.05	74476.76
EBIT QOQ	0.56	0.08	-86.49
EPS QOQ	0.37	0.17	-55.13
FCF QOQ	1.69	-0.72	-57.17
Revenue QOQ	0.06	-0.07	3.61
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	95.92	107.02	11.58
Days Sales Outstanding (DSO)	89.76	99.43	10.77
Inventory Turnover	0.94	0.84	-10.37
Debt/Capitalization	0.42	0.39	-7.19
Quick Ratio	1.19	1.18	-0.95
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	14.76	14.86	0.67
Cash	4.16	4.05	-2.75
Capex	-0.15	-0.10	31.48
Free Cash Flow	1.33	0.37	-72.24
Revenue	8.88	8.27	-6.90
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.88	1.88	-0.15
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.88	6.20	-21.37
Naive Interpretation	Member

06 - Financial Health · Weak

Rating